Publications by authors named "Kent Miner"

Claim this Profile
D
Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.
Ming Zhang, Francis Lee, Anna Knize, Frederick Jacobsen, Steven Yu, Kent Miner

Clin Exp Rheumatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways.
Kent Miner, Katja Labitzke, Benxian Liu, Paul Wang, Kathryn Henckels

Front Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitors.
Felix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, Mario Cardozo, Yi Chen, Kent Miner

J Med Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.
Hailing Hsu, Sanjay D Khare, Frances Lee, Kent Miner, Yi-Ling Hu

Clin Exp Rheumatol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppression.
Leslie J Dickmann, Helen J McBride, Sonal K Patel, Kent Miner, Larry C Wienkers

Biochem Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Ryan P Wurz, Liping H Pettus, Bradley Henkle, Lisa Sherman, Matthew Plant, Kent Miner

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Ryan P Wurz, Liping H Pettus, Shimin Xu, Bradley Henkle, Lisa Sherman, Kent Miner

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis